News|Articles|December 20, 2024
Molecular Properties of PROTACs and the Relationship to Formulation Design
Author(s)Bend BioScience
Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
FDA Activity Round Up – July 2026
3
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
4
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
5